Lexicon Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Lexicon Pharmaceuticals has a total shareholder equity of $240.0M and total debt of $99.5M, which brings its debt-to-equity ratio to 41.5%. Its total assets and total liabilities are $373.4M and $133.4M respectively.
Key information
41.5%
Debt to equity ratio
US$99.50m
Debt
Interest coverage ratio | n/a |
Cash | US$309.96m |
Equity | US$239.98m |
Total liabilities | US$133.38m |
Total assets | US$373.36m |
Recent financial health updates
Here's Why Lexicon Pharmaceuticals (NASDAQ:LXRX) Can Manage Its Debt Despite Losing Money
Aug 08Is Lexicon Pharmaceuticals (NASDAQ:LXRX) A Risky Investment?
Apr 25Does Lexicon Pharmaceuticals (NASDAQ:LXRX) Have A Healthy Balance Sheet?
Jan 04Recent updates
Lexicon Pharmaceuticals Needs To See Real Revenue Acceleration And Clinical/Regulatory Success
Aug 03Lexicon Pharmaceuticals: Blue Sky Aplenty, Revenue Not So Much
May 28Lexicon Pharmaceuticals: Moving To Maximize The Value Of Its Core Asset
Mar 12Lexicon Pharmaceuticals Putting The Pieces Together, But Much Is Left To Do
Jan 26Here's Why Lexicon Pharmaceuticals (NASDAQ:LXRX) Can Manage Its Debt Despite Losing Money
Aug 08Is Lexicon Pharmaceuticals (NASDAQ:LXRX) A Risky Investment?
Apr 25Does Lexicon Pharmaceuticals (NASDAQ:LXRX) Have A Healthy Balance Sheet?
Jan 04Financial Position Analysis
Short Term Liabilities: LXRX's short term assets ($320.8M) exceed its short term liabilities ($27.9M).
Long Term Liabilities: LXRX's short term assets ($320.8M) exceed its long term liabilities ($105.5M).
Debt to Equity History and Analysis
Debt Level: LXRX has more cash than its total debt.
Reducing Debt: LXRX had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: LXRX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: LXRX has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 17.6% each year.